• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GXE:GR

14.680 EUR 0.104 0.71%

As of 03:48:43 ET on 12/22/2014.

Snapshot for Galapagos NV (GXE)

Open: 14.381 Day's Range: 14.381 - 14.680 Volume: 240
Previous Close: 14.576 52wk Range: 10.020 - 18.230 1-Yr Rtn: +5.16%

Stock Chart for GXE

No chart data available.
  • GXE:GR 14.680
  • 1D
  • 1M
  • 1Y
14.576
Interactive GXE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GXE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.7200
Est. PEG Ratio -
Market Cap (M EUR) 444.52
Shares Outstanding (M) 30.28
30 Day Average Volume 60
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GXE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GXE

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorBart FiliusChief Financial Officer
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
More Company Profile & Key Executives for GXE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil